B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera

Immune gene expression profiling of PBMC isolated from horses vaccinated with attenuated African horsesickness virus serotype 4

(2016) A. Pretorius et al.   IMMUNOBIOLOGY

African horse sickness virus serotype 4 antigens, VP1-1, VP2-2, VP4, VP7 and NS3, induce cytotoxic T cell responses in vitro

(2016) F.E. Faber et al.   VIRUS RESEARCH

Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge

(2015) Eva Calvo-Pinilla et al.   ANTIVIRAL RESEARCH

Characterization of a second open reading frame in genome segment 10 of bluetongue virus

(2015) Meredith Stewart et al.   JOURNAL OF GENERAL VIROLOGY

Virus uncoating is required for apoptosis induction in cultured mammalian cells infected with African horse sickness virus

(2015) Elaine Vermaak et al.   JOURNAL OF GENERAL VIROLOGY

Comprehensive serological profiling of human populations using a synthetic human virome

(2015) G. J. Xu et al.   SCIENCE

Identification of CD8 T cell epitopes in VP2 and NS1 proteins of African horse sickness virus in IFNAR(-/-) mice.

(2015) Francisco de la Poza et al.   VIRUS RESEARCH

High-throughput sequencing enhanced phage display enables the identification of patient-specific epitope motifs in serum

(2015) Anders Christiansen et al.   Scientific Reports

Characterising Non-Structural Protein NS4 of African Horse Sickness Virus

(2015) Lizahn Zwart et al.   PLoS One

Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge

(2014) F. Feenstra et al.   JOURNAL OF GENERAL VIROLOGY

Rapid Profiling of the Antigen Regions Recognized by Serum Antibodies Using Massively Parallel Sequencing of Antigen-Specific Libraries

(2014) Maria Domina et al.   PLoS One

Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus

(2014) Yuta Kanai et al.   VACCINE

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge

(2014) Berta Alberca et al.   VACCINE

High-Throughput Sequencing Enhanced Phage Display Identifies Peptides That Bind Mycobacteria

(2013) Nqobile A. C. Ngubane et al.   PLoS One

Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation

(2013) Eva Calvo-Pinilla et al.   VIRUS RESEARCH

Structural Insight into African Horsesickness Virus Infection

(2012) V. Manole et al.   JOURNAL OF VIROLOGY

Structural analysis of B-cell epitopes in antibody:protein complexes

(2012) Jens Vindahl Kringelum et al.   MOLECULAR IMMUNOLOGY

Conserved Proline-Rich Region of Ebola Virus Matrix Protein VP40 Is Essential for Plasma Membrane Targeting and Virus-Like Particle Release

(2011) Olivier Reynard et al.   JOURNAL OF INFECTIOUS DISEASES

Generation of Replication-Defective Virus-Based Vaccines That Confer Full Protection in Sheep against Virulent Bluetongue Virus Challenge

(2011) E. Matsuo et al.   JOURNAL OF VIROLOGY

Phage Display: Selecting Straws Instead of a Needle from a Haystack

(2011) Miha Vodnik et al.   MOLECULES

Detection of a Fourth Orbivirus Non-Structural Protein

(2011) Mourad Belhouchet et al.   PLoS One

A reverse genetics system of African horse sickness virus reveals existence of primary replication

(2010) Eiko Matsuo et al.   FEBS LETTERS

Bluetongue Virus VP6 Acts Early in the Replication Cycle and Can Form the Basis of Chimeric Virus Formation

(2009) E. Matsuo et al.   JOURNAL OF VIROLOGY